{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Computerized+Tomography+scan&page=37", "query": { "intervention": "Computerized Tomography scan", "page": 37 }, "page_size": 10 }, "pagination": { "page": 37, "page_size": 10, "total_count": 2066, "total_pages": 207, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Computerized+Tomography+scan&page=38&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Computerized+Tomography+scan&page=36&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T02:38:17.845Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06225427", "title": "Gilteritinib for the Treatment of ALK NSCLC", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Non-Small Cell Carcinoma", "Stage IV Lung Cancer AJCC v8" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Echocardiography", "type": "PROCEDURE" }, { "name": "Gilteritinib", "type": "DRUG" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" }, { "name": "Questionnaire Administration", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2024-07-25", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-06-26", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 3, "location_summary": "Los Angeles, California • Washington D.C., District of Columbia • Ann Arbor, Michigan", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT06225427" }, { "nct_id": "NCT04143516", "title": "Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Liver Metastases" ], "interventions": [ { "name": "[18-F]- FDG - PET", "type": "DIAGNOSTIC_TEST" }, { "name": "Tumor ablation (TA)", "type": "PROCEDURE" }, { "name": "PET/CT Scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST", "PROCEDURE" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2019-10-25", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04143516" }, { "nct_id": "NCT06900595", "title": "Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Locally Advanced Adrenal Cortical Carcinoma", "Metastatic Adrenal Cortical Carcinoma", "Recurrent Adrenal Cortical Carcinoma", "Stage III Adrenal Cortical Carcinoma AJCC v8", "Stage IV Adrenal Cortical Carcinoma AJCC v8", "Unresectable Adrenal Cortical Carcinoma" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Cabozantinib", "type": "DRUG" }, { "name": "Cemiplimab", "type": "BIOLOGICAL" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 48, "start_date": "2026-02-22", "completion_date": "2029-06-02", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 81, "location_summary": "Phoenix, Arizona • La Jolla, California • Madera, California + 60 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Madera", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT06900595" }, { "nct_id": "NCT02780128", "title": "Next Generation Personalized Neuroblastoma Therapy", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuroblastoma", "Cancer" ], "interventions": [ { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "Next Generation Sequencing", "type": "GENETIC" }, { "name": "Tumor Scans", "type": "PROCEDURE" }, { "name": "Bone marrow Tests", "type": "PROCEDURE" }, { "name": "Physical Exam", "type": "OTHER" }, { "name": "Eye Exam", "type": "OTHER" }, { "name": "Labs", "type": "OTHER" }, { "name": "Pregnancy Test", "type": "OTHER" }, { "name": "Interviews", "type": "BEHAVIORAL" }, { "name": "ECG", "type": "OTHER" }, { "name": "Echocardiogram", "type": "OTHER" }, { "name": "Ribociclib", "type": "DRUG" }, { "name": "Ceritinib", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "GENETIC", "OTHER", "BEHAVIORAL", "DRUG" ], "sponsor": "Yael P Mosse", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "21 Years", "sex": "ALL", "summary": "1 Year to 21 Years" }, "enrollment_count": 66, "start_date": "2016-07", "completion_date": "2022-08", "has_results": false, "last_update_posted_date": "2026-03-10", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02780128" }, { "nct_id": "NCT06732401", "title": "Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lung Non-Small Cell Carcinoma", "Stage II Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8" ], "interventions": [ { "name": "Biospecimen Collection", "type": "PROCEDURE" }, { "name": "Ceralasertib", "type": "DRUG" }, { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Durvalumab", "type": "BIOLOGICAL" }, { "name": "Echocardiography Test", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "DRUG", "BIOLOGICAL" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 630, "start_date": "2025-08-07", "completion_date": "2028-06-30", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 192, "location_summary": "Jonesboro, Arkansas • Beverly Hills, California • Los Angeles, California + 163 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Tarzana", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06732401" }, { "nct_id": "NCT01764919", "title": "[124I]FIAU PET-CT Scanning in Diagnosing Osteomyelitis in Patients With Diabetic Foot Infection", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diabetic Foot Infection" ], "interventions": [ { "name": "[124I]FIAU", "type": "RADIATION" } ], "intervention_types": [ "RADIATION" ], "sponsor": "BioMed Valley Discoveries, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2013-04", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 3, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • Philadelphia, Pennsylvania", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01764919" }, { "nct_id": "NCT06720142", "title": "Mg OSTEOCRETE Post-Treatment Outcomes", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cancer of Bone", "Trauma", "Aseptic Loosening of Orthopaedic Hardware" ], "interventions": [ { "name": "Mg OSTEOCRETE as a bone void filler", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Santiago Lozano-Calderon", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10, "start_date": "2025-03-17", "completion_date": "2028-03-17", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT06720142" }, { "nct_id": "NCT02664883", "title": "Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Healthy Subject", "Metastatic Renal Cell Cancer", "Recurrent Renal Cell Carcinoma", "Stage I Renal Cell Cancer", "Stage II Renal Cell Cancer", "Stage III Renal Cell Cancer" ], "interventions": [ { "name": "Computed Tomography", "type": "PROCEDURE" }, { "name": "Cytology Specimen Collection Procedure", "type": "OTHER" }, { "name": "Laboratory Biomarker Analysis", "type": "OTHER" }, { "name": "Magnetic Resonance Imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE", "OTHER" ], "sponsor": "University of Southern California", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 37, "start_date": "2015-09-08", "completion_date": "2026-10-29", "has_results": false, "last_update_posted_date": "2026-04-02", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02664883" }, { "nct_id": "NCT03860857", "title": "Biomarker Exploration in Aging, Cognition and Neurodegeneration", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Alzheimer Disease", "Cognitive Impairment", "Cognitive Decline" ], "interventions": [ { "name": "Amyloid PET scan", "type": "RADIATION" }, { "name": "Tau PET scan using MK-6240", "type": "DRUG" }, { "name": "Neurocognitive testing", "type": "BEHAVIORAL" }, { "name": "MRI", "type": "OTHER" } ], "intervention_types": [ "RADIATION", "DRUG", "BEHAVIORAL", "OTHER" ], "sponsor": "University of California, Irvine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 300, "start_date": "2018-05-01", "completion_date": "2027-12-22", "has_results": false, "last_update_posted_date": "2026-01-23", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "Irvine, California", "locations": [ { "city": "Irvine", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03860857" }, { "nct_id": "NCT03852654", "title": "18F-DCFPyL PET-CT Scan and Prostate Cancer", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Prostate Cancer Adenocarcinoma" ], "interventions": [ { "name": "18F-DCFPyL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Lida Jafari", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 170, "start_date": "2018-07-22", "completion_date": "2020-06-30", "has_results": false, "last_update_posted_date": "2019-02-25", "last_synced_at": "2026-10-23T02:38:17.845Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03852654" } ] }